---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-037764"
form_type: "8-K"
ticker: "RVPH"
cik: "0001742927"
company_name: "REVIVA PHARMACEUTICALS HOLDINGS, INC."
filed_at: "2024-12-18T23:59:59+00:00"
generated_at: "2026-05-29T02:03:04.107408+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Reviva prices $18M public offering of 12M shares and warrants

## Summary
- Offering of 12M shares of common stock plus Series A warrants (6M shares, 6-month term) and Series B warrants (12M shares, 5-year term) at $1.50/unit.
- Gross proceeds $18M; net proceeds ~$15.8M after underwriting discounts and expenses.
- Series A warrants exercisable at $1.50, expire in 6 months; Series B warrants at $1.50, expire in 5 years.
- Expected closing on December 18, 2024; Citizens JMP Securities is sole bookrunner.
- Proceeds to fund R&D, working capital, and general corporate purposes.

## SEC filing metadata
- accession: 0001437749-24-037764
- form_type: 8-K
- ticker: RVPH
- cik: 0001742927
- company_name: REVIVA PHARMACEUTICALS HOLDINGS, INC.
- filed_at: 2024-12-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1742927/000143774924037764/0001437749-24-037764-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1742927/000143774924037764/rvph20241217_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-037764
- JSON: https://secwatch.observer/filing/0001437749-24-037764.json
- Plain text: https://secwatch.observer/filing/0001437749-24-037764.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.